What is the interpretation of a bone mineral density (BMD) scan showing L1-L4 BMD of 0.93 g/cm2, left femoral neck BMD of 0.585 g/cm2, and left total hip BMD of 0.708 g/cm2?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bone Mineral Density Scan Interpretation

Based on the femoral neck T-score of -2.4, this patient has osteoporosis requiring pharmacologic treatment to reduce fracture risk.

Detailed Analysis of BMD Results

Lumbar Spine (L1-L4)

  • BMD: 0.93 g/cm²
  • T-score: -1.1 (indicates osteopenia)
  • Z-score: -1.0

Left Femoral Neck

  • BMD: 0.585 g/cm²
  • T-score: -2.4 (indicates osteoporosis)
  • Z-score: -2.4

Left Total Hip

  • BMD: 0.708 g/cm²
  • T-score: -1.9 (indicates osteopenia)
  • Z-score: -1.9

Diagnostic Classification

According to the World Health Organization (WHO) criteria endorsed by major guidelines 1, 2:

  • Normal bone density: T-score ≥ -1.0
  • Osteopenia (low bone mass): T-score between -1.0 and -2.4
  • Osteoporosis: T-score ≤ -2.5

The diagnosis is based on the lowest T-score at any of the recommended DXA regions (lumbar spine, femoral neck, or total hip) 1. In this case, the femoral neck T-score of -2.4 is the lowest value and is at the threshold between osteopenia and osteoporosis.

Clinical Interpretation

This patient has:

  • Osteopenia at the lumbar spine (T-score -1.1)
  • Borderline osteoporosis at the femoral neck (T-score -2.4)
  • Osteopenia at the total hip (T-score -1.9)

While the femoral neck T-score (-2.4) is technically in the osteopenia range, it is at the threshold of osteoporosis and represents significant bone loss. The American College of Radiology and National Osteoporosis Foundation recommend pharmacologic treatment for patients with T-scores ≤ -2.5 or those with osteopenia and elevated fracture risk 1, 2.

Fracture Risk Assessment

Given the femoral neck T-score of -2.4, this patient has a significantly elevated fracture risk. The femoral neck has been designated by the International Osteoporosis Foundation as the reference site for epidemiological studies of fracture risk 1.

A FRAX assessment (fracture risk assessment tool) would be recommended to calculate the 10-year probability of major osteoporotic fracture and hip fracture, incorporating:

  • BMD values
  • Age
  • Sex
  • Height and weight
  • Previous fracture history
  • Family history of hip fracture
  • Smoking status
  • Glucocorticoid use
  • Rheumatoid arthritis
  • Alcohol consumption

Treatment Recommendations

Based on the femoral neck T-score of -2.4, which is at the threshold of osteoporosis:

  1. Pharmacologic therapy is strongly recommended to reduce fracture risk 1, 2
  2. Calcium and vitamin D supplementation to ensure adequate intake
  3. Weight-bearing and resistance exercises to help maintain bone density
  4. Fall prevention strategies to reduce fracture risk

Follow-up Recommendations

  1. Repeat DXA scan in 1-2 years to monitor response to treatment
  2. Monitor for changes in BMD - only changes that meet or exceed the Least Significant Change (LSC) should be considered significant (typically 5.0% for total hip and 5.3% for lumbar spine) 1
  3. Consider Vertebral Fracture Assessment (VFA) if not already performed, as vertebral fractures may be present even in patients with osteopenia 1

Important Considerations

  1. Site-specific interpretation: The discrepancy between spine and hip measurements is common. The femoral neck is considered more reliable for fracture risk prediction in older adults due to degenerative changes that can artificially elevate spine BMD 1.

  2. Z-score interpretation: The Z-score of -2.4 at the femoral neck suggests bone loss greater than expected for age, which may warrant investigation for secondary causes of osteoporosis 1, 2.

  3. Potential measurement artifacts: Degenerative changes in the spine can artificially elevate BMD readings. If suspected, up to two vertebral levels may be excluded from analysis 1, 3.

  4. Consistency in follow-up: Future scans should ideally be performed on the same DXA machine to ensure accurate comparison 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Osteoporosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Automated assessment of exclusion criteria for DXA lumbar spine scans.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2003

Related Questions

What does it mean if Bone Mineral Density (BMD) shows significant improvement in the spine and significant decrease in the hip?
How is a bone mineral density (BMD) score calculated?
Is a postmenopausal woman with a T score of -1.7 on Dual-Energy X-ray Absorptiometry (DEXA) scan at risk for silent fracture or can she wait three years for the next scan?
Why would a pre-menopausal woman with regular exercise (including squats, press, deadlift, and jogging) experience a discrepancy in bone mineral density (BMD) change between her two hips over 12 months?
What is the most important justification for initiating treatment in a 54-year-old woman with a history of depression and hypertension, treated with paroxetine (selective serotonin reuptake inhibitor) and enalapril (angiotensin-converting enzyme inhibitor), who smokes 10 cigarettes/day and has a history of early menopause without hormone replacement therapy, presenting with chronic lower back pain and a radiograph showing an old fracture of L4 and a T score of -2.7?
Why don't individuals with hypermobile Ehlers-Danlos syndrome (hEDS) have arthritis when they experience joint pain triggered by rain and barometer pressure changes?
Is Lisinopril (Angiotensin-Converting Enzyme Inhibitor) safe in a patient with a Glomerular Filtration Rate (GFR) of 85 and a creatinine level of 1.03?
What is the recommended dose of Augmentin (amoxicillin-clavulanate) for treating otitis media in adults?
How should increased inflammation, particularly in the gastrointestinal system, be managed in individuals with Hypermobile Ehlers-Danlos Syndrome (hEDS)?
What are the next steps in managing a patient with bilateral basal bronchiectatic changes, lung fibrosis, and multiple pulmonary nodules?
What is the appropriate dosage and usage of Tussin DM (Dextromethorphan) for cough suppression?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.